Upgrading ultrasound imaging capabilities for preclinical research
升级临床前研究的超声成像能力
基本信息
- 批准号:MR/X012530/1
- 负责人:
- 金额:$ 40.45万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to understand diseases, we use - among many other tools - mouse models of human diseases. These animals are designed to mimic human diseases so the origin and processes leading to these diseases can be studied. Once we understand better how the diseases come about, we can test treatments to improve disease, and both understanding disease and testing approaches to treat disease are aspects of our research projects.In order to follow how diseases progress and/or how treatments improve these diseases, we need imaging tools that allow us to see what is going on inside the body of a living animal. One great technique for this is ultrasound. It is a non-invasive, pain-free technique. An imaging head (called 'transducer') is placed on the skin and the ultrasound waves can penetrate into the body, These sound waves are then reflected off any tissues they meet and return as 'echoes' that are picked up by the same transducer before being converted to a moving image. Ultrasound imaging is also widely used in clinical settings (e.g. to monitor the growth of embryos inside the womb during pregnancy). However, due to the small size of the animals used, the ultrasound used in our research needs much better spatial resolution than in clinically used machines. Moreover, for research focussing on the heart, the beating rate of animal models is roughly ten times faster than that of humans, so also the temporal resolution needs to be much better. We are requesting equipment with such specifications that will allow us to carry out ultrasound imaging in animal models of disease. The majority of research projects using the equipment will focus on cardiovascular diseases, however, we will expand the application of ultrasound imaging to other areas, such as cancer and liver disease. The new ultrasound imaging equipment, called VevoF2, will replace old, now obsolete equipment. It will have better specifications, hence allowing us to reduce the burden on animals in research by using less animals and at points where the disease has less progressed. Moreover, the new ultrasound equipment comes with software packages that use novel tools and techniques to make better use of the images recorded. It will allow us to get more information out of these images, e.g. about blood flow in the heart or blood vessels by a technique called tissue Doppler.Due to the modular nature of the new equipment, hard- and software extensions can be bought in the future to adapt the equipment to new applications or research questions, e.g. to implement the use of contrast agents to better visualise tumours.
为了了解疾病,我们使用了许多其他工具-人类疾病的小鼠模型。这些动物旨在模仿人类疾病,以便研究导致这些疾病的起源和过程。一旦我们更好地了解了疾病的发生,我们就可以测试治疗方法来改善疾病,而了解疾病和测试治疗疾病的方法都是我们研究项目的一个方面。为了跟踪疾病的进展和/或治疗方法如何改善这些疾病,我们需要成像工具,使我们能够看到活体动物体内发生了什么。一个很好的技术是超声波。这是一种无创、无痛的技术。将成像头(称为“换能器”)放置在皮肤上,超声波可以穿透到体内,然后这些声波从它们遇到的任何组织反射并作为“回波”返回,这些回波在转换为移动图像之前由同一换能器拾取。超声成像也广泛用于临床环境(例如,监测怀孕期间子宫内胚胎的生长)。然而,由于使用的动物体积小,我们研究中使用的超声需要比临床使用的机器更好的空间分辨率。此外,对于专注于心脏的研究,动物模型的跳动速度大约是人类的10倍,因此时间分辨率也需要更好。我们正在要求具有这种规格的设备,使我们能够在疾病的动物模型中进行超声成像。使用该设备的大多数研究项目将集中在心血管疾病上,然而,我们将把超声成像的应用扩展到其他领域,如癌症和肝病。新的超声成像设备称为VevoF 2,将取代旧的,现在已经过时的设备。它将有更好的规格,从而使我们能够通过使用更少的动物和疾病进展较少的点来减轻研究中动物的负担。此外,新的超声波设备配备了软件包,使用新的工具和技术,以更好地利用记录的图像。它将使我们能够从这些图像中获得更多信息,例如通过一种称为组织多普勒的技术了解心脏或血管中的血流。由于新设备的模块化特性,未来可以购买硬件和软件扩展,以使设备适应新的应用或研究问题,例如使用造影剂更好地可视化肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katja Gehmlich其他文献
Characterisation of infantile cardiomyopathy in Alström syndrome using emALMS1/em knockout induced pluripotent stem cell derived cardiomyocyte model
使用EMALMS1/EM基因敲除诱导多能干细胞衍生的心肌细胞模型的Alström综合征中婴儿心肌病的表征
- DOI:
10.1016/j.ymgme.2024.108575 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:3.500
- 作者:
Leena Patel;Ashwin Roy;Jonathan Barlow;Christopher O'Shea;Daniel Nieves;Amar J. Azad;Caitlin Hall;Ben Davies;Phalguni Rath;Davor Pavlovic;Ashish Chikermane;Tarekegn Geberhiwot;Richard P. Steeds;Katja Gehmlich - 通讯作者:
Katja Gehmlich
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
- DOI:
10.1038/s41598-025-94371-w - 发表时间:
2025-03-24 - 期刊:
- 影响因子:3.900
- 作者:
Lisa Leinhos;Paul Robinson;Giulia Poloni;Sophie Broadway-Stringer;Julia Beglov;Adam B. Lokman;Gillian Douglas;Sajjad Nuthay;Oveena Fonseka;Manuel Schmid;Evie Singer;Charlotte Hooper;Kate Thomson;Richard D. Bagnall;Jodie Ingles;Christopher Semsarian;Elizabeth Ormondroyd;Christopher N. Toepfer;Benjamin Davies;Charles Redwood;Hugh Watkins;Katja Gehmlich - 通讯作者:
Katja Gehmlich
Filamin C dimerisation is regulated by HSPB7
细丝蛋白 C 的二聚化受 HSPB7 调节
- DOI:
10.1038/s41467-025-58889-x - 发表时间:
2025-05-01 - 期刊:
- 影响因子:15.700
- 作者:
Zihao Wang;Guodong Cao;Miranda P. Collier;Xingyu Qiu;Sophie Broadway-Stringer;Dominik Šaman;Jediael Z. Y. Ng;Navoneel Sen;Amar J. Azad;Charlotte Hooper;Johannes Zimmermann;Michael A. McDonough;Jürgen Brem;Patrick Rabe;Haigang Song;T. Reid Alderson;Christopher J. Schofield;Jani R. Bolla;Kristina Djinovic-Carugo;Dieter O. Fürst;Bettina Warscheid;Matteo T. Degiacomi;Timothy M. Allison;Georg K. A. Hochberg;Carol V. Robinson;Katja Gehmlich;Justin L. P. Benesch - 通讯作者:
Justin L. P. Benesch
Arrhythmogenesis in Fabry Disease
- DOI:
10.1007/s11886-024-02053-2 - 发表时间:
2024-04-12 - 期刊:
- 影响因子:3.300
- 作者:
Ashwin Roy;Max J. Cumberland;Christopher O’Shea;Andrew Holmes;Manish Kalla;Katja Gehmlich;Tarekegn Geberhiwot;Richard P. Steeds - 通讯作者:
Richard P. Steeds
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
- DOI:
10.1007/s10974-011-9268-3 - 发表时间:
2011-11-05 - 期刊:
- 影响因子:1.700
- 作者:
Steven Marston;O’Neal Copeland;Katja Gehmlich;Saskia Schlossarek;Lucie Carrrier - 通讯作者:
Lucie Carrrier
Katja Gehmlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katja Gehmlich', 18)}}的其他基金
The interactions between filamin C and small heat-shock proteins in cardiac mechanosignalling
细丝蛋白 C 和小热休克蛋白在心脏机械信号传导中的相互作用
- 批准号:
MR/V009540/1 - 财政年份:2021
- 资助金额:
$ 40.45万 - 项目类别:
Research Grant
相似国自然基金
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
- 批准号:82370780
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
超声多信号融合高浓度液固/液液两相流在线测量方法研究
- 批准号:50706029
- 批准年份:2007
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
生物素-亲和素介导超声造影剂对乳腺癌血管生成分子靶向显像的研究
- 批准号:30670580
- 批准年份:2006
- 资助金额:26.0 万元
- 项目类别:面上项目
超声微泡造影剂携靶基因治疗及其声像图监控研究
- 批准号:30430230
- 批准年份:2004
- 资助金额:130.0 万元
- 项目类别:重点项目
超声微泡介导基因转染过程适宜空化效果的研究
- 批准号:30400419
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
超声微泡造影剂介导靶基因治疗梗死性血管病及机制研究
- 批准号:30370402
- 批准年份:2003
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
ERI: Non-Contact Ultrasound Generation and Detection for Tissue Functional Imaging and Biomechanical Characterization
ERI:用于组织功能成像和生物力学表征的非接触式超声波生成和检测
- 批准号:
2347575 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Standard Grant
CAREER: Super-Resolution 3D Ultrasound Imaging of Brain Activity
职业:大脑活动的超分辨率 3D 超声成像
- 批准号:
2237309 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
Continuing Grant
Magnetic Resonance Imaging (MRI) and Artificial Intelligence (AI) can improve preoperative malignancy risk prediction of ovarian masses.
磁共振成像(MRI)和人工智能(AI)可以改善卵巢肿块的术前恶性肿瘤风险预测。
- 批准号:
486885 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
Operating Grants
Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme
使用 MRI 引导聚焦超声联合 5-氨基乙酰丙酸的声动力疗法治疗复发性多形性胶质母细胞瘤
- 批准号:
10699858 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
Role of serum advanced glycation end-products in altering tendon properties with diabetes
血清晚期糖基化终末产物在改变糖尿病肌腱特性中的作用
- 批准号:
10737036 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
Towards treatment for the complex patient: investigations of low-intensity focused ultrasound.
针对复杂患者的治疗:低强度聚焦超声的研究。
- 批准号:
10775216 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别:
Mechanisms and Functions of Cortical Activity to Restore Behavior
皮层活动恢复行为的机制和功能
- 批准号:
10737217 - 财政年份:2023
- 资助金额:
$ 40.45万 - 项目类别: